Edwards Lifesciences Aktie
WKN: 936853 / ISIN: US28176E1082
23.04.2015 22:59:54
|
Edwards Lifesciences Q1 Results Top Estimates
(RTTNews) - Edwards Lifesciences Corp. (EW) reported net income for the first quarter of $123.4 million or $1.12 per share, compared to $60.3 million or $0.56 per share for the year-ago quarter.
Net sales for the first quarter quarter rose 13% to $590.3 million from $522.4 million a year ago.
Analysts polled by Thomson Reuters expected the company to earn $1.04 per share on revenue of $584.79 million for the first quarter. Analysts' estimates typically exclude special items.
Looking forward to second quarter, the company forecasts total sales of $580 million to $620 million and adjusted earnings of $1.00 to $1.10 per share. Analysts currently expect the company to earn $1.05 per share on revenue of $604.26 million for the second quarter.
The company now expects full year 2015 total sales to be within its original guidance of $2.3 billion to $2.5 billion. However, the company narrowed its full year 2015 adjusted earnings per share guidance to a range of $4.10 to $4.30 from its previous range of $4.00 to $4.30. Analysts currently expect the company to earn $4.21 per share on revenue of $2.40 billion for the full year 2015.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Edwards Lifesciences Corp.mehr Nachrichten
Analysen zu Edwards Lifesciences Corp.mehr Analysen
Aktien in diesem Artikel
Edwards Lifesciences Corp. | 68,03 | -0,44% |
|